CorrespondenceJournal of Pharmacology and PharmacotherapeuticsVol. 6 | Issue 4 | 2015 | pp. 233–233Open access
Are we moving towards a new definition of essential medicines?
- 1*
- 1 Department of Pharmacology, Weill Cornell Medical College, New York, USA.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Marcus M. Reidenberg
Department of Pharmacology, Weill Cornell Medical College, New York, USA.
Email: mmreid@med.cornell.edu
Copyright: © 2015 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2015
- Received:
- Sep 30, 2015
- Accepted:
- Oct 16, 2015
How to cite
Reidenberg, M. M. (2015). Are we moving towards a new definition of essential medicines? Journal of Pharmacology and Pharmacotherapeutics, 6(4), 233. https://doi.org/10.4103/0976-500X.171874
Abstract
The problems of health care in 1977 when the definition of an essential medicine was written were different than those of 2015. Then the focus was on helping developing countries improve the inadequate health care available for many people in these countries.[2] Infectious disease was upmost in people’s minds. Thirty‑nine anti‑infective drugs were in the main list then, along with seven antineoplastic drugs. Around 1990, some middle‑income countries desired advice about cancer medicines. A World Health Organization (WHO) consultation was held and divided cancer medicines into three categories: Drugs that significantly prolonged survival, those that improved quality of life, and those that did neither.[3] An expert committee decided that those in the first two categories were essential. It appears that this determination that drugs in these two categories are essential continues to the present.
Keywords
Subject
Article metadata
| Title | Are we moving towards a new definition of essential medicines? |
|---|---|
| Authors | Marcus M. Reidenberg |
| Affiliations | Department of Pharmacology, Weill Cornell Medical College, New York, USA. |
| Corresponding author | mmreid@med.cornell.edu |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 6, Issue 4 (2015) |
Also in this issue
- Trivializing assessment: A key factor in undermining the standards of medical educationpp. 195–197
- A comparative study of the clinical efficacy and safety of agomelatine with escitalopram in major depressive disorder patients: A randomized, parallel‑group, phase IV studypp. 198–203
- Vasorelaxation of goat mesenteric artery is mediated by endothelial Na+‑K+‑ATPasepp. 204–210
- Successful management of malignant hyperpyrexia syndrome in a pediatric patient: What to do when dantrolene is not available?pp. 211–213
- Mirtazapine withdrawal‑induced maniapp. 214–215
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026